HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brittle cornea syndrome 1

A hereditary autosomal recessive disorder characterized by by blue SCLERA, corneal rupture after minor trauma, KERATOCONUS or keratoglobus, hyperelasticity of the skin, and hypermobility of the joints. Mutations in the ZNF469 gene have been identified. OMIM: 229200.
Also Known As:
Brittle cornea syndrome; Corneal fragility, keratoglobus, blue sclerae, joint hyperextensibility; Dysgenesis Mesodermalis Corneae et Sclerae; Ehlers-Danlos Syndrome, Type VIB; Ehlers-Danlos syndrome 6B; Fragilitas oculi with joint hyperextensibility
Networked: 11 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1. Keratoconus
2. Connective Tissue Diseases (Connective Tissue Disease)
3. Corneal Perforation
4. Spontaneous Perforation
5. Posterior Amorphous Corneal Dystrophy

Experts

1. Black, Graeme C: 2 articles (12/2015 - 10/2014)
2. Porter, Louise F: 2 articles (12/2015 - 10/2014)
3. Aldave, Anthony J: 1 article (01/2021)
4. Barrington, Alice: 1 article (01/2021)
5. Chen, Angela C: 1 article (01/2021)
6. Chung, Doug D: 1 article (01/2021)
7. Frausto, Ricardo F: 1 article (01/2021)
8. Magalhaes, Otavio A: 1 article (01/2021)
9. Yung, Madeline: 1 article (01/2021)
10. Zhang, Junwei: 1 article (01/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Brittle cornea syndrome 1:
1. Proteins (Proteins, Gene)FDA Link
2. Transcription Factors (Transcription Factor)IBA
3. 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA
4. HydroxylysineIBA
5. Histones (Histone)IBA
6. CollagenIBA
7. Anesthetics (Anesthetic Agents)IBA
8. cytoplasmic protein A (PACD)IBA
9. zinc-binding protein (zinc binding protein)IBA

Therapies and Procedures

1. Penetrating Keratoplasty
2. Therapeutics
3. Corneal Cross-Linking